Related Experiment Video
Updated: Jun 11, 2026

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well
Published on: February 27, 2026
Point-of-care testing in haemostasis.
David J Perry1, David A Fitzmaurice, Steve Kitchen
1Department of Haematology, Addenbrooke's Hospital, Cambridge, UK. david.perry@addenbrookes.nhs.uk
Point-of-care testing (POCT) in hematology is expanding, offering faster results for patient care. Ensuring accuracy and precision in these tests, especially in hemostasis, is crucial despite challenges in quality control.
Area of Science:
- Hematology
- Clinical Pathology
- Point-of-Care Testing (POCT)
Background:
- POCT in hematology has significantly increased in test availability and annual performance.
- POCT is often implemented to reduce result turnaround times, aiming to improve patient care.
- Key applications include monitoring International Normalized Ratio (INR) for warfarin, Activated Clotting Time (ACT) during cardiopulmonary bypass, platelet function assays, and thrombelastography.
Purpose of the Study:
- To highlight the expanding role of POCT in hematology, particularly in hemostasis.
- To underscore the importance of accurate and precise results generated by POCT.
- To address the challenges associated with POCT, including operator training and quality control.
Main Methods:
- Review of current applications and trends in hematology POCT.
- Discussion of specific POCT assays used in hemostasis.
- Analysis of quality control and external quality assessment (EQA) for POCT.
Main Results:
- POCT is increasingly used for various hematological tests, including hemostasis monitoring.
- Challenges exist regarding operator training and adherence to strict quality control programs compared to central laboratories.
- Existing external quality assessment programs for POCT assays are limited.
Conclusions:
- The use of POCT in hematology, especially in hemostasis, is expected to grow.
- Robust systems are essential to guarantee the accuracy and precision of POCT results.
- Addressing quality control and operator training is vital for the safe expansion of POCT.
Related Concept Videos
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
